Measuring perceived activity limitations in lower extremity Complex Regional Pain Syndrome type 1 (CRPS I): test-retest reliability of two questionnaires
Restricted accessResearch articleFirst published online June, 2002
Measuring perceived activity limitations in lower extremity Complex Regional Pain Syndrome type 1 (CRPS I): test-retest reliability of two questionnaires
Objective: To assess the test–retest reliability of two questionnaires for measuring activity limitations in patients with Complex Regional Pain Syndrome type 1 (CRPS I) of the lower extremity.
Design: Patients filled out the Walking Stairs Questionnaire and the Questionnaire Rising and Sitting Down twice during a one-week period.
Setting: Outpatient pain clinic of a university hospital.
Patients: Twenty-one outpatients with CRPS I of the lower extremity.
Results: The Walking Stairs Questionnaire and the Questionnaire Rising and Sitting Down were reliable in terms of test–retest reliability as expressed by Spearman's r (range 0.79–0.90 and 0.85–0.89 respectively) and the ICC (range 0.78–0.84 and 0.84–0.87 respectively).
Conclusion: Both questionnaires form a reliable tool for measuring activity limitations of patients with CRPS I of a lower extremity.
Get full access to this article
View all access options for this article.
References
1.
Birklein F, Riedl B, Sieweke N, Weber M, Neundorfer B. Neurological findings in complex regional pain syndromes – analysis of 145 cases. Acta Neurol Scand2000; 101: 262–269.
2.
Galer BS, Butler S, Jensen MP. Case report and hypothesis: a neglect-like syndrome may be responsible for the motor disturbance in re‘ex sympathetic dystrophy (Complex Regional Pain Syndrome-1). J Pain Symptom Manage1995; 10: 385–391.
3.
Galer BS, Jensen MP. Neglect-like symptoms in complex regional pain syndrome; results of a self-administered survey. J Pain Symptom Manage1999; 18: 213–217.
4.
Kozin F. Re‘ex sympathetic dystrophy syndrome: a review. Clin Exp Rheumatol1992; 10: 401–409.
5.
Masson C, Audran M, Pascaretti C et al. Further vascular, bone and autonomic evaluations in algodystrophy. Acta Orthop Bel1998; 64: 77–87.
Schwartzman RJ, Kerrigan J. The movement disorder of re‘ex sympathetic dystrophy. Neurology1990; 40: 57–61.
8.
International classification of functioning and disability: ICIDH-2. Beta-2 draft: short version. Geneva, World Health Organization, 1999.
9.
Oerlemans HM, Cup EH, Boo T, Goris RJA, Oostendorp RAB. The Radboud skills questionnaire: construction and reliability in patients with re‘ex sympathetic dystrophy of one upper extremity. Disabil Rehabil2000; 20,22: 233–245.
10.
Roorda LD, Roebroeck ME, Lankhorst GJ, Tilburg TG van. The walking ability questionnaire: hierarchical scales to measure disabilities in rising and walking [in Dutch]. Revalidata1996; 18: 34–38.
11.
Roorda LD, Roebroeck ME, Lankhorst GJ, Tilburg T van, Bouter LM. Measuring functional limitations in rising and sitting down: development of a questionnaire. Arch Phys Med Rehabil1996; 77: 663–669.
12.
Veldman PHJM, Reynen HM, Arnzt IE, Goris RJA. Signs and symptoms of re‘ex sympathetic dystrophy: prospective study of 829 patients. Lancet1993; 342: 1012–1016.
13.
Portney LG, Watkins MP. Foundations of clinical practice: applications to practice. Norwalk: Appleton and Lange, 1993.
14.
Altman DG. Practical statistics for medical research. New York: Chapman and Hall, 1999.
15.
Zuurmond WWA, Langendijk PJN, Bezemer PD, Brink HE, Lange JJ de, Loenen AC van. Treatment of acute re‘ex sympathetic dystrophy with DMSO 50% in a fatty cream: a randomised double blind placebo controlled study. Acta Anesthesiol Scand1996; 40: 364–367.
